GlassScriptPhysician profile
Amber Lee Shipman
NPI 1346660834
$462.15
in general payments reported to CMS, 2019-2025
11 companies · $214 in 2025
The $214 reported for 2025 was more than what 76% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $14.70 · 2023: $85.96 · 2024: $148 · 2025: $214.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $447.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $447.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $113.43 | 2023-2025 | Azstarys |
| Tris Pharma INC | $71.92 | 2025 | Dyanavel Xr |
| Supernus Pharmaceuticals, INC. | $51.62 | 2024-2025 | Qelbree |
| Pfizer INC. | $44.01 | 2024-2025 | |
| Sobi, INC | $32.33 | 2022-2023 | |
| Alk-Abello, INC | $30.49 | 2024 | Odactra, Grastek, Ragwitek |
| Merck Sharp & Dohme LLC | $29.94 | 2023-2024 | Gardasil 9, Vaxelis, Vaxneuvance |
| Cranial Technologies, INC | $28.93 | 2025 | Doc Band |
| Sanofi-Aventis U.S. LLC | $25.50 | 2025 | |
| Collegium Pharmaceutical, INC. | $18.18 | 2025 | Jornay Pm |
| Mirum Pharmaceuticals, INC. | $15.80 | 2024 | Cholbam |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amber Shipman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.